RAMM Pharma

RAMM Pharma EBIT per Share

The EBIT per Share of RAMM Pharma (RAMM.CN) as of Oct 11, 2026 is -0.04 CAD. In the previous year, EBIT per Share was -0.06 CAD — a change of -36.37% (higher).

EBIT per Share

-0.04CAD

YoY

-36.37%

Last updated:

EBIT per Share of RAMM Pharma is 2025 -0.04 CAD. EBIT per Share of RAMM Pharma was 2024 -0.06 CAD. It decreases by -36.37% higher compared to the previous year.

The RAMM Pharma EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
0.00 CAD
Jan 1, 2019
-0.05 CAD
Jan 1, 2020
-0.08 CAD
Jan 1, 2021
-0.05 CAD
Jan 1, 2022
-0.06 CAD
Jan 1, 2023
-0.06 CAD
Jan 1, 2024
-0.06 CAD
Jan 1, 2025
-0.04 CAD
The RAMM Pharma EBIT per Share history
YEAREBIT per ShareYoY
-0.04CAD-36.37%
-0.06CAD-4.57%
-0.06CAD-8.59%
-0.06CAD+20.37%
-0.05CAD-29.18%
-0.08CAD+38.43%
-0.05CAD-1,761.18%
0.00CAD—
Access this data via the Eulerpool API
Get Free API Key

RAMM Pharma Stock analysis

What does RAMM Pharma do? RAMM Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RAMM Pharma stock

EBIT per Share of RAMM Pharma is -0.04 CAD in 2025.

EBIT per Share of RAMM Pharma changed from -0.06 CAD to -0.04 CAD, representing a -36.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share RAMM Pharma since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — RAMM Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — RAMM Pharma